ACE inhibitor and potassium salt substitute — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Salt substitutes may contain potassium and increase hyperkalaemia risk
Many low-sodium salt substitutes contain potassium chloride. In a patient taking an ACE inhibitor and spironolactone, additional potassium can increase hyperkalaemia risk. The other options either delay appropriate care, use an unsuitable medicine, or miss the main safety issue.
Reference: BNF